On April 25, 2022, Impel NeuroPharma, Inc. changed its name to Impel Pharmaceuticals.
IPI Legacy Liquidation Co
Equities
IMPL
US45258K1097
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+67.53% | 6.39TCr | |
-0.77% | 4.18TCr | |
+44.98% | 4.05TCr | |
-10.87% | 2.72TCr | |
+13.30% | 2.65TCr | |
-22.79% | 1.87TCr | |
+4.70% | 1.27TCr | |
+24.10% | 1.21TCr | |
+27.41% | 1.21TCr |